Synedgen Inc.

PureTech Health plc, after the multibillion-dollar success of its last neuropsychiatry venture Karuna Therapeutics Inc., launched Seaport Therapeutics in April with $100m in series A funding and on 21

Three venture capital funds announced during the last two weeks of October have $989m to invest in life science companies, which should help keep the biopharmaceutical VC financing boom going beyond 2

Biopharma start-up fundraising more than doubled to $3.87bn in the second quarter versus the prior quarter, helped by initial public offerings, including the Actelion Pharmaceuticals Ltd. spinout

IN VITRO DIAGNOSTICS ACT Genomics Co. Ltd. ACT Genomics closes $12.5mm Series B round ACT Genomics Co. Ltd. (molecular diagnostics and precision cancer care) raised $12.5mm through its Series